Bispecific Antibody Pipeline Congress 2018 | Checkpoint-binding Bispecific Antibodies - a podcast by Cambridge Healthtech Podcasts

Dr. John Haurum shares his perspective on the future of bispecific antibodies in the next 5 years, common myths about immune system activation using bispecifics and some novel compounds inside and outside of IO fields that he’s looking forward to the most at the Bispecific Antibody Pipeline Congress.

For more information, please visit http://www.BispecificAntibodyCongress.com/Bispecific-Antibody-Clinical-Relevance

Further episodes of CHI Podcasts

Further podcasts by Cambridge Healthtech Podcasts

Website of Cambridge Healthtech Podcasts